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In this issue of Annals of Surgical Oncology, Park et al.
present an interesting study analyzing patterns of lymph
node metastasis in patients with right-sided colon cancer.1
With a large cohort of 419 patients, they studied the dis-
tribution of lymph nodes metastasis along the different
arteries of right and transverse colon according to the
location of adenocarcinoma. For cancer located from
cecum to hepatic flexure, they found lymph node metas-
tasis along ileocolic artery, right colic artery, and middle
colic artery. For proximal transverse colon cancer, no
lymph node metastasis was found along ileocolic artery.
On the basis of their results, they propose some guidelines
for surgical resection of right-sided colon cancer: ileocecal
resection for cecal cancer does not seem oncologically
safe, and resection preserving ileocolic artery and ileocolic
valve performed for transverse colon cancer seems
reasonable.
The extent of colon resection is principally based on
tumor location and lymphadenectomy sacrificing colic
arteries. Distal margins are rarely a problem, which
imposes an extension of colic resection. There is no con-
sensus on the extent of lymphadenectomy for colon cancer,
and in particular for transverse colon cancer. Anatomic
variations in the distribution of the right-sided colic arteries
make it hard to standardize lymphadenectomy. This lack of
consensus is one of the reasons why transverse colon
cancers were excluded from the prospective randomized
trials that evaluated findings of cancer in laparoscopic
colectomies.2–5
Lymphadenectomy for colon cancer may have three
interests: prognosis, cure, and a measure of quality of colon
cancer care. The prognostic value of lymphadenectomy is
now clearly established. Lymph node staging has a direct
impact on adjuvant therapy. Many studies have demon-
strated an improvement of survival correlated with a higher
number of nodes in lymphadenectomy.6–8 Chen et al., in
their study based on a large cohort of 82,896 patients,
reported a statistically significant improvement of
54 months for median survival with stage II disease if[15
nodes were removed, compared with those in whom \7
nodes were removed.7 This important difference can be
explained by the better staging of disease. It was shown
that the risk of understaging (and thus undertreatment) is
approximately 10% if\13 nodes were removed.9 A higher
median survival was also found for stage III disease. The
same results were also observed in the Intergroup Trial
INT-0089.8 Five-year overall survival increased from 67%
to 90% for N1 disease (1 to 10 lymph nodes removed vs.
[40), and from 51% to 71% for N2 disease (1 to 35 lymph
nodes removed vs. [35). These differences were on par
with or better than the best reported results for various
adjuvant chemotherapies with even the newest combina-
tion adjuvant chemotherapy regimens.
These results suggest that extensive lymphadenectomy
may have a curative value because stage migration cannot
explain the results observed for N2 disease. The number of
lymph nodes recovered from a patient with colon cancer
has been identified as a potentially important measure of
the quality of cancer care by many organizations, including
the American College of Surgeons and the American
Society of Clinical Oncology. Despite the previous results,
there is still controversy over the importance of obtaining
increased numbers of lymph nodes during colon cancer
surgery. The International Union Against Cancer proposed
a minimum of 12 lymph nodes.10 However, compliance
with this guideline is poor. In the population-based study of
Chen et al., in\50% of right colon cancer cases and\40%
of transverse colon cancer cases, the number of lymph
nodes removed was [11.7 A randomized, controlled trial
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would be necessary to definitively establish the minimum
number of lymph nodes to be removed. This study is not
possible until all of the determinants of lymph node num-
bers can be controlled.
As a result of the lack of evidence, and because of the
limited morbidity of lymphadenectomy for right-sided
colon cancer, extensive mesenteric lymphadenectomy
should be considered.
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